FDA.reportPublic FDA data

Sutent 50 MG Oral Capsule

RxCUI
616292
RxNorm name
Sutent 50 MG Oral Capsule
Display name
Sutent 50 MG Oral Capsule
Full name
Sutent 50 MG Oral Capsule
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:56

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SUTENTSUNITINIB MALATEPfizer Laboratories Div Pfizer Inc43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c2026-02-20Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 616292

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9cSutent 50 MG Oral Capsule [PSN] · sunitinib 50 MG Oral Capsule [Sutent] [SBD] · Sutent 50 MG (as sunitinib malate 66.8 MG) Oral Capsule [SY] · Sutent 50 MG Oral Capsule [SY]450These highlights do not include all the information needed to use SUTENT safely and effectively. See full prescribing information for SUTENT. SUTENT ® (sunitinib malate) capsules, for oral use Initial U.S. Approval: 200620260220